GHK-Cu peptide enhances cell proliferation and antibacterial activity on collagen/chitosan scaffolds
Background
Effective wound healing and skin repair remain significant clinical challenges, especially when dealing with extensive tissue loss. Current strategies often involve synthetic scaffolds to provide a structural template for new tissue growth. However, many synthetic materials like poly(ε-caprolactone) (PCL) lack inherent biological activity. To address this, researchers are exploring composite scaffolds, such as those incorporating collagen and chitosan, which mimic the natural extracellular matrix. Even with these additions, enhancing bioactivity is crucial for accelerating healing. Bioactive glasses and peptides like GHK-Cu are known to promote tissue regeneration. This study investigates whether surface modification of a PCL/collagen/chitosan scaffold with GHK-Cu or 58S bioactive glass can further improve its biological properties, specifically cell growth and resistance to infection.
Study Design
This in vitro study fabricated electrospun poly(ε-caprolactone) (PCL) scaffolds coated with collagen and chitosan. These base scaffolds were then surface-modified by pipetting either a solution of 1-mM GHK-Cu peptide or suspensions of silanized 58S bioactive glass powder at three different concentrations. The successful surface modification was confirmed using ATR-FTIR spectroscopy. Researchers then performed microstructural investigations and a series of in vitro assays to evaluate the biological properties, including cell adhesion, cell viability, and an antibacterial assay. The performance of the GHK-Cu and bioactive glass-coated scaffolds was compared against the uncoated PCL/collagen/chitosan scaffold, which served as the control.
Results
All scaffold variations, including the control, demonstrated desirable cell attachment. The key enhancements were seen in cell proliferation and antibacterial action. Compared to the poly(ε-caprolactone)/collagen/chitosan control, the scaffolds coated with GHK-Cu showed a significant increase in cell proliferation by day 3. Scaffolds coated with bioactive glass (at concentrations of 0.01 and 0.1) also showed significantly increased cell proliferation, but this effect was observed later, at day 7. While all tested scaffolds, including the uncoated control, exhibited desirable antibacterial properties, the performance of the GHK-Cu-coated samples was notably better.
The antibacterial activity of the GHK-Cu-coated sample turned out to be superior to both the bioactive glass-coated and the uncoated control scaffolds.
Key Findings
- Scaffolds coated with GHK-Cu peptide showed a significant increase in cell proliferation by day 3 compared to the control.
- The antibacterial activity of GHK-Cu-coated scaffolds was superior to that of both bioactive glass-coated and uncoated control scaffolds.
- All tested scaffolds, including the uncoated PCL/collagen/chitosan base, demonstrated desirable cell attachment.
- Bioactive glass-coated scaffolds (at 0.01 and 0.1 concentrations) also significantly increased cell proliferation, but not until day 7.
- ATR-FTIR spectroscopy confirmed the successful surface modification of the scaffolds with both GHK-Cu and bioactive glass.
Why It Matters
This research provides strong evidence for using GHK-Cu as a surface coating to enhance the bioactivity of wound-healing scaffolds. For researchers and developers in tissue engineering, this suggests that GHK-Cu is a highly effective additive for improving both cellular regeneration and antimicrobial defense in a single modification step. The finding that GHK-Cu's proliferative effects manifest earlier (by day 3) than those of bioactive glass could be clinically significant for accelerating the initial stages of wound closure. For potential therapeutic applications, incorporating GHK-Cu into advanced bandages or implantable scaffolds could lead to faster, more robust, and infection-resistant skin repair. This study is a preclinical step, but it validates a promising strategy for developing next-generation wound care products. Further in vivo studies are needed to confirm these benefits in a living organism before clinical protocols can be considered.
TitrateLab articles covering GHK-Cu
Written by TitrateLab, separately from the study summarized above.
ghk-cu
wound healing
skin repair
tissue engineering
in vitro
scaffold
